Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Help & Advice
University of Warwick

The Library

  • Login
  • Admin

Stroke prevention in atrial fibrillation : we can do better

Tools
- Tools
+ Tools

Kearney, M., Fay, M. and Fitzmaurice, David (2016) Stroke prevention in atrial fibrillation : we can do better. British Journal of General Practice, 66 (643). pp. 62-63. doi:10.3399/bjgp16X683557

Research output not available from this repository.

Request-a-Copy directly from author or use local Library Get it For Me service.

Official URL: http://dx.doi.org/10.3399/bjgp16X683557

Request Changes to record.

Abstract

Atrial fibrillation (AF), an irregular and often rapid cardiac rhythm, is the most common sustained cardiac dysrhythmia. Prothrombotic changes in the atrium encourage local clot formation with potential for embolisation to the cerebral circulation, conferring a fivefold increase in risk of stroke. It is estimated that one in five strokes, and one in three over the age of 80 years, are directly attributable to AF. Strokes that are due to AF also have a much worse outcome, with significantly higher mortality rates and greater long-term disability. At the same time we have very effective preventive treatments, with anticoagulants reducing the risk of ischaemic stroke by around 70%. Reflecting this, National Institute for Health and Care Excellence (NICE)1 and European consensus2 guidance recommends that we offer structured risk assessment followed by anticoagulation for people identified as at high risk. This pathway of diagnosis, assessment, and management does not generally require specialist input and should be regarded as essential primary care. So how well are we doing and could we do better?

Item Type: Journal Item
Divisions: Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Clinical Trials Unit
Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Health Sciences
Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School
Journal or Publication Title: British Journal of General Practice
Publisher: Royal College of General Practitioners
ISSN: 0960-1643
Official Date: 27 January 2016
Dates:
DateEvent
27 January 2016Published
Volume: 66
Number: 643
Page Range: pp. 62-63
DOI: 10.3399/bjgp16X683557
Status: Peer Reviewed
Publication Status: Published
Access rights to Published version: Open Access (Creative Commons)

Request changes or add full text files to a record

Repository staff actions (login required)

View Item View Item
twitter

Email us: wrap@warwick.ac.uk
Contact Details
About Us